Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $47.08 USD
Change Today +0.30 / 0.64%
Volume 3.0M
As of 8:04 PM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas C. Freyman

Chief Financial Officer and Executive Vice President of Finance, Abbott Laboratories
AgeTotal Calculated CompensationThis person is connected to 18 board members in 6 different organizations across 9 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Thomas C. Freyman has been the Chief Financial Officer and Executive Vice President of Finance at Abbott Diabetes Care, Inc. since 2001 and February 2004, respectively. Mr. Freyman has been Chief Financial Officer of Abbott Laboratories since 2001 and as its Executive Vice President of Finance since 2004. He serves as the Chief Executive Officer and Chief Financial Officer of Abbott Health Products Inc. He joined Abbott on February 1, 1979, where he served in a number ...

Read Full Background

Corporate Headquarters*

100 Abbott Park Road
Abbott Park, Illinois 60064

United States

Phone: 847-937-6100
Fax: --

Board Members Memberships*

Former Director
Former Director
Director and Member of Audit Committee


University of Illinois-Urbana-Champaign
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,012,604

Stock Options*

Restricted Stock Awards$1,281,024
All Other Compensation$164,011
Exercised Options79,000
Exercised Options Value$1,473,842
Exercisable Options636,400
Unexercisable Options435,777
Total Value of Options$1,473,842
Total Number of Options1,151,177

Total Compensation*

Total Annual Cash Compensation$2,376,615
Total Short Term Compensation$1,012,604
Other Long Term Compensation$1,445,035
Total Calculated Compensation$7,307,828
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:US $47.08 USD +0.30


Marc N. Casper Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee
Thermo Fisher Scientific, Inc.
Emmanuel Faber Chief Executive Officer, Vice Chairman, Member of Social Responsibility Committee and Member of Strategy Committee
Thomas P. Joyce Jr.Chief Executive Officer, President, Director and Member of Finance Committee
Danaher Corp.
Kendall J. Powell Chairman and Chief Executive Officer
General Mills, Inc.
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at